These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1381185)

  • 1. Induction and detection of anti-peptide antibody specificity is critically affected by the mode of hapten presentation.
    Moroder L; Papini A; Siglmüller G; Köcher K; Dörrer E; Schneider CH
    Biol Chem Hoppe Seyler; 1992 Jun; 373(6):315-21. PubMed ID: 1381185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fully synthetic immunogens. Part III. Synthesis of hinge-peptide/gastrin conjugates and their immunological properties.
    Wünsch E; Moroder L; Hübener G; Musiol HJ; Von Grünigen R; Göhring W; Scharf R; Schneider CH
    Int J Pept Protein Res; 1991 Feb; 37(2):90-102. PubMed ID: 1708369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of cholecystokinin: comparison of different tracers.
    Cantor P; Rehfeld JF
    J Immunol Methods; 1985 Sep; 82(1):47-55. PubMed ID: 2411820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of rabbit antibody specific for amino-terminal residues of cholecystokinin octapeptide (CCK-8) by selective suppression of cross-reactive antibody response.
    Hashimura E; Shimizu F; Nishino T; Imagawa K; Tateishi K; Hamaoka T
    J Immunol Methods; 1982 Dec; 55(3):375-87. PubMed ID: 6300248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme immunoassay with captured hapten. A sensitive gastrin assay with biotinyl-gastrin derivatives.
    von Grünigen R; Siglmüller G; Papini A; Köcher K; Traving B; Göhring W; Moroder L
    Biol Chem Hoppe Seyler; 1991 Mar; 372(3):163-72. PubMed ID: 2054095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate measurement of cholecystokinin in plasma.
    Rehfeld JF
    Clin Chem; 1998 May; 44(5):991-1001. PubMed ID: 9590372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of antisera to cholecystokinin by use of different cholecystokinin labels.
    Jansen JB; Lamers CB
    J Immunol Methods; 1984 Jun; 71(1):1-8. PubMed ID: 6539353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reactivity of mononucleotides with cholecystokinin/gastrin antisera.
    Rehfeld JF
    Regul Pept; 1983 Apr; 6(1):33-41. PubMed ID: 6867379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on immunoassays of peptide factors. III. Gastrin/iso-1-cytochrome C as immunogen for raising anti-gastrin antisera.
    Moroder L; Mourier G; Dufresne M; Bovermann G; Göhring W; Gemeiner M; Wünsch E
    Biol Chem Hoppe Seyler; 1987 Jul; 368(7):839-48. PubMed ID: 3040037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phylogeny of the cholecystokinin/gastrin family.
    Johnsen AH
    Front Neuroendocrinol; 1998 Apr; 19(2):73-99. PubMed ID: 9578981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational analysis of possible biologically active (receptor-bound) conformations of peptides derived from cholecystokinin, cerulein and little gastrin and the opiate peptide, Met-enkephalin.
    Pincus MR; Murphy RB; Carty RP; Chen J; Shah D; Scheraga HA
    Peptides; 1988; 9 Suppl 1():145-52. PubMed ID: 2856638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes.
    Edwards RJ; Singleton AM; Murray BP; Davies DS; Boobis AR
    Biochem Pharmacol; 1995 Jan; 49(1):39-47. PubMed ID: 7840781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of cholecystokinin-pancreozymin.
    Harvey RF; Dowsett L; Hartog M; Read AE
    Gut; 1974 Sep; 15(9):690-9. PubMed ID: 4435583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones.
    Stone SR; Giragossian C; Mierke DF; Jackson GE
    Peptides; 2007 Nov; 28(11):2211-22. PubMed ID: 17950490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genuine and apparent cross-reaction of polyclonal antibodies to proteins and peptides.
    Leder L; Wendt H; Schwab C; Jelesarov I; Bornhauser S; Ackermann F; Bosshard HR
    Eur J Biochem; 1994 Jan; 219(1-2):73-81. PubMed ID: 8307037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cholecystokinin/gastrin peptides in frog and turtle. Evidence that cholecystokinin is phylogenetically older than gastrin.
    Johnsen AH; Rehfeld JF
    Eur J Biochem; 1992 Jul; 207(2):419-28. PubMed ID: 1633800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular nature of cholecystokinin in plasma. An in vivo immunosorption study in rabbits.
    Rehfeld JF
    Scand J Gastroenterol; 1994 Feb; 29(2):110-21. PubMed ID: 8171278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides in rat brain immunoreactive for the amino terminus of cholecystokinin 33: distribution and chromatography.
    Han SP; Allard LR; Beinfeld MC
    Biochem Biophys Res Commun; 1987 Dec; 149(3):902-7. PubMed ID: 3426615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supersensitive gastrin assay using antibodies raised against a cholecystokinin homolog.
    Rehfeld JF; Ericsson P
    Scand J Clin Lab Invest; 2012 Apr; 72(2):175-9. PubMed ID: 22136177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residue-specific radioimmunoanalysis: a novel analytical tool. Application to the C-terminus of CCK/gastrin peptides.
    Rehfeld JF; Morley JS
    J Biochem Biophys Methods; 1983 Feb; 7(2):161-70. PubMed ID: 6833712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.